Abstract
Pleiotropic growth factors play a number of critical roles in continuous processes of embryonic development; however, the mechanisms by which a single regulatory factor is able to orchestrate diverse developmental events remain imperfectly understood. In the development of the enteric nervous system (ENS), myenteric ganglia (MGs) form initially, after which the submucosal ganglia (SMGs) develop by radial inward migration of immature ENS precursors from the myenteric layer. Here, we demonstrate that glial cell line-derived neurotrophic factor (GDNF) is essential for the formation not only of the MGs, but the SMGs as well, establishing GDNF as a long-term acting neurotrophic factor for ENS development in a mouse model. GDNF promotes radial migration of SMG precursors. Interestingly, premigratory SMG precursors in the myenteric layer were distinguished from the surrounding neuronally differentiating cells by their lower activation of the GDNF-mediated MAPK pathway, suggesting that low activation of GDNF downstream pathways is required for the maintenance of the immature state. ENS precursors devoid of GDNF signaling during midgestation halt their migration, survive, and remain in an undifferentiated state over the long-term in vivo. Reactivation of GDNF signaling in these dormant precursors restores their migration and neuronal differentiation in gut organ culture. These findings suggest that pleiotropic function of GDNF is at least in part governed by modulating levels of intracellular activation of GDNF downstream pathways; high activation triggers neuronal differentiation, whereas low activation is crucial for the maintenance of progenitor state.
Introduction
Embryonic development is a highly complex, dynamic process that requires exquisite orchestration of cellular proliferation, migration, differentiation, and maintenance of progenitor cells. Cells are exposed to a number of growth factors during development, some of which are expressed for long periods, inducing various cellular responses in tissue progenitors and their progeny. Because impaired regulation of progenitors causes many developmental disorders, it is crucial to understand how a single growth factor governs the behavior of progenitors, including migration, proliferation, and differentiation, and regulates the maintenance of in-tissue progenitors in an undifferentiated state.
The enteric nervous system (ENS) serves as an interesting model for the study of long-term developmental processes in response to a single growth factor. In mice, vagal neural crest (NC) cells enter the foregut at embryonic day (E) 9.5 (Durbec et al., 1996) and migrate caudally until they colonize the entire length of the gut, at ∼E14. After colonization, the majority of ENS precursors form the myenteric ganglia (MGs), while a subset of ENS precursors undergoes radial migration from the myenteric to the submucosal layer to form the submucosal ganglia (SMGs) (Gershon et al., 1993). Most MG precursors become postmitotic by birth, but some SMG precursors proliferate until postnatal day 15 (P15; Pham et al., 1991). Thus, ENS precursors forming the SMGs remain in an immature state for a long period of time.
Glial cell line-derived neurotrophic factor (GDNF) is expressed in the gut mesenchyme (Young et al., 2001; Natarajan et al., 2002), binds preferentially to GDNF family receptor α1 (GFRα1), and activates the RET tyrosine kinase (Jing et al., 1996; Baloh et al., 2000), which is expressed in ENS precursor cells (Pachnis et al., 1993; Durbec et al., 1996; Young et al., 2003). As GDNF signaling is required for ENS precursor proliferation and migration (Chalazonitis et al., 1998; Hearn et al., 1998; Heuckeroth et al., 1998; Taraviras et al., 1999; Gianino et al., 2003; Uesaka et al., 2007), null mutations of Gdnf, Gfrα1, or Ret cause intestinal aganglionosis in mice (Schuchardt et al., 1994; Moore et al., 1996; Pichel et al., 1996; Sánchez et al., 1996; Cacalano et al., 1998; Enomoto et al., 1998). Interestingly, ENS precursors retain responsiveness to GDNF signaling even after birth (Wang et al., 2010), suggesting a role for GDNF in regulating precursor behaviors during both embryonic and postnatal ENS development.
Here, we demonstrate that GDNF signaling is essential for both primary rostrocaudal and secondary radial migration of ENS precursors, establishing that GDNF has a long-term impact on the driving force of ENS precursor migration. Interestingly, ENS precursors retained in the MGs exhibit minimal activation of MAPK in response to GDNF, suggesting that limited availability of GDNF is crucial for the maintenance of the immature state in ENS precursors. Consistent with this notion, we provide evidence that ENS precursors maintain their undifferentiated state in vivo when GDNF signaling is abrogated in those cells during midgestation. Our data modify our current understanding of the mechanism by which a single neurotrophic factor can regulate precursor cell expansion and differentiation during normal and abnormal ENS development.
Materials and Methods
Animals.
Gfra1fl(GFP) (Uesaka et al., 2007), Retfl(CFP) (Uesaka et al., 2008), RetCreERT2 (Luo et al., 2009), and RetBcl-xL (Uesaka and Enomoto, 2010) mice were generated as previously described. Heterozygous mice harboring Gfrα1 green fluorescent protein (GFP) knock-in (Gfrα1GFP/+) or Ret cyan fluorescent protein (CFP) knock-in alleles (RetCFP/+) were obtained by crossing Gfra1fl(GFP) or Retfl(CFP) mice to β-actin::Cre mice (ACTB::Cre, Jackson Laboratories; Lewandoski et al., 1997). For time-specific inactivation of Gfrα1 or Ret, Gfra1fl(GFP) or Retfl(CFP) mice were crossed to Gfrα1 heterozygous mice (Gfrα1+/−; Enomoto et al., 1998) or Ret heterozygous mice (Ret+/−) (Gould et al., 2008) ubiquitously expressing inducible Cre recombinase (CAGGCre-ER, Jackson Laboratories; Hayashi and McMahon, 2002) referred to as CAG::CreER/Gfrα1+/− or CAG::CreER/Ret+/−, respectively. Cre activity was induced by a single intraperitoneal injection of 4-hydroxytamoxifen (4-OHT; 0.5 mg per mouse; Sigma) into pregnant mothers. Nrtn (Heuckeroth et al., 1999) or Artn (Honma et al., 2002) heterozygous mice (Nrtn+/− or Artn+/−) were generously provided by J. Milbrandt (Washington University, St. Louis, MO). GdnflacZ mice (Moore et al., 1996; a kind gift from V. Pachnis, MRI-NIMR, London, UK) were used to track expression of GDNF in the gastrointestinal tract by β-galactosidase (βgal) immunostaining. Mice of either sex were used in this study.
Immunostaining.
Tissues were fixed with 4% paraformaldehyde in 1× PBS containing 10 mm phosphate buffer, pH 7.4, 137 mm sodium chloride, and 2.7 mm potassium chloride. Fetuses or dissected gut were fixed from 2 h to overnight at 4°C, whereas cultures were fixed for 20 min at ambient temperature. For preparations of E10.5–E15.5 gut, the entire intestinal tract was fixed intact and processed for immunohistochemistry. For E16.5 and older animals, the small intestine was opened and pinned flat before fixation. After brief fixation, the muscle layers were removed. For frozen sections, fixed preparations were cryoprotected (15% sucrose at 4°C), embedded in O.C.T. Compound (Sakura Finetek), frozen, and cryosectioned. For whole-mount staining, the preparations were incubated in 1% Triton X-100 for 30 min before immunostaining. Immunostaining was performed as described previously (Enomoto et al., 1998), except for anti-GDNF antibody immunostaining. Immunostaining of anti-GDNF antibody was performed without any detergents to avoid the diffusion of antigens. The following antibodies were used: rabbit anti-PGP9.5 (1:1000; Ultra Clone); goat anti-Sox10 (1:400, Santa Cruz Biotechnology); mouse anti-TuJ1 (1:500; Covance); goat anti-β-galactosidase (1:400; Biogenesis); rabbit anti-phospho-ERK1/2 (1:500; Cell Signaling Technology); and rabbit anti-GDNF (1:200; Santa Cruz Biotechnology). We also used a chicken anti-GFP (1:1000; Aves Laboratories), which can recognize variants of GFP such as CFP and YFP. Secondary antibodies used were DyLight 488 (1:500; Thermo Scientific), and Alexa Fluor 488, 594, or 647 (1:500, Invitrogen). Fluorescent imaging was performed using a Zeiss Axioskop 2FS plus system. Confocal images were acquired using a LSM5 PASCAL system (Carl Zeiss). ImageJ (US National Institutes of Health) was used to measure fluorescence intensities of Alexa Fluor 594 antibody [phospho-ERK (pERK)] in each cell.
Gut organ culture.
One day after administration of 4-OHT at E10.5, the gastrointestinal tract was dissected from each fetus and placed in tissue culture medium [DMEM containing 10% fetal calf serum (FCS), 2 mm glutamine, and 100 IU/ml penicillin/100 μg/ml streptomycin] at 37°C with 5% CO2. Gut organ was cultured in the presence of bovine serum albumin (BSA) or GFRα1-Fc (500 ng/ml; R&D Systems) and/or GDNF (50 ng/ml; R&D Systems) before fixing.
Time-lapse imaging.
Embryonic gut from Gfrα1fl(GFP)/+/CAG::CreER (control) and Gfrα1fl(GFP)/−/CAG::CreER (conditional knock-out) fetuses was dissected and attached to a thin strip of filter membrane (HABG047S0, Merck Millipore) by pressing a piece of mesentery to the membrane strip with the tips of forceps. The filter membrane was floated tissue-side down on a 27 mm coverslip window of a glass-bottomed dish to avoid direct contact of the gut tissue with the glass bottom. The gut was cultured in DMEM containing 10% of FCS and penicillin/streptomycin at 37°C with 5% CO2 in a time-lapse incubator and examined by an inverted fluorescent microscope (Axiovert 200M, Carl Zeiss) with a CCD camera (Axiocam MRm, Carl Zeiss). For time-lapse imaging, GFP images were obtained every 5 min for 4–28 h.
Statistical analysis.
Statistical analysis was performed using a t test with Welch's correction and Mann–Whitney U test. Results are expressed as the mean ± SEM.
Results
GDNF is required for ENS precursor migration to form both the myenteric and submucosal plexus
To investigate the physiological role of GDNF in ENS precursors during formation of the MGs and SMGs in vivo, Gfrα1fl(GFP) mice, in which the expression of Gfrα1can be replaced by the expression of GFP (Uesaka et al., 2007), were crossed to Gfrα1+/− mice (Enomoto et al., 1998) harboring the CAG::CreER transgene to obtain Gfrα1fl(GFP)/+/CAG::CreER (control) or conditional knock-out (cKO) embryos in the same litters. In these conditional mouse lines, a chimeric Cre protein fused to the mutated ligand-binding domain of the estrogen receptor is expressed ubiquitously, and treatment of pregnant mothers with 4-OHT-induced Cre activity in utero. We inactivated Gfrα1 at E10.5 and analyzed early gut colonization by ENS precursors (Fig. 1A). In control embryos, many GFP+ cells reached the ileocecal junction, whereas they colonized only the middle portion of the midgut in cKO fetuses (Fig. 1B). We confirmed that GFP+ cells in the migratory wavefront were Sox10+ ENS precursors, most of which are undifferentiated (Young et al., 2004; Fig. 1C). By time-lapse imaging, we compared migratory behaviors between control and cKO ENS precursors. In control gut, GFP+ ENS precursors undergoing dynamic movement near the ileocecal junction exhibited polarized morphology and migrated with cyclic motions; that is, the protrusion of the leading edge was followed by a subsequent cell body translocation (Fig. 1D, top panels). Gfrα1 cKO ENS precursors also exhibited polarized morphology similar to that of control cells. In contrast, the motility of the cell body was slowed in cKO ENS precursors (Fig. 1D, bottom panels). We found that the average velocity of the cell movement decreased significantly in cKO fetuses (control, 57.4 ± 4.8 μm/min, n = 18 cells; cKO, 13.5 ± 0.6 μm/min, n = 16 cells; p < 0.05, unpaired t test with Welch's correction). These results indicate that GDNF signaling is essential for the enhancement of ENS precursor migration.
GDNF is essential for ENS precursor migration to form both the MGs and SMGs. A, 4-OHT was administrated to pregnant females at E10.5. Embryonic guts were dissected out from control and Gfrα1 cKO fetuses 16 h after injection of 4-OHT, and were cultured in the time-lapse incubator. B, GFP+ cells (green) in the gut of control and Gfrα1 cKO fetuses 16 h after treatment with 4-OHT. In the control fetuses, GFP+ cells entered the hindgut, whereas inactivation of Gfrα1 impaired colonization of the gut by ENS precursors. C, Whole-mount GFP (green) and an ENS precursor marker, Sox10 (magenta), staining of ENS precursors in the migratory wavefront along the gut from the control fetuses. GFP+ cells coexpressed Sox10, indicating immature ENS precursors. D, Selected frames from time-lapse fluorescent imaging for the migration of GFP-labeled ENS precursors from control and Gfrα1 cKO explants. Images were acquired at 5 min intervals. E, Schematic diagram showing rostral-to-caudal colonization of the midgut by ENS precursors and secondary inward migration toward the submucosal region. F, Histological analysis of E16.5 Gfrα1GFP/+ SMGs showing Gfrα1 expression (as revealed by GFP, green) in Sox10+ ENS precursors (blue) and PGP9.5+ neurons (magenta). G, Control and Gfrα1 cKO fetuses were subjected to 4-OHT treatment at E15.5. H, Whole-mount GFP (green) and PGP9.5 (magenta) staining of the SMGs in the small intestine from E18.5 control and Gfrα1 cKO fetuses. Scale bars: B–D, 50 μm; F, H, 20 μm.
ENS precursors complete rostrocaudal migration across the entire gut until E14.5. After the formation of the MGs, inward migration of ENS precursors occurs, giving rise to the SMGs (Fig. 1E). To address the question of whether GDNF also controls radial migration of ENS precursors, we first examined the expression of Gfrα1 in ENS precursors undergoing radial migration by using Gfrα1GFP/+ mice, which express GFP under the control of endogenous Gfrα1 promoter (Uesaka et al., 2007). We confirmed that Sox10+ ENS precursors in the submucosal region expressed Gfrα1 at E16.5 (Fig. 1F), suggesting that the GDNF signal may be also required for radial migration of ENS precursors. We therefore inactivated Gfrα1 at E15.5, and the submucosal region was analyzed at E18.5 by whole-mount immunostaining against GFP and PGP9.5 (Fig. 1G). In control fetuses, many GFP+ neurons were observed in the submucosal region (Fig. 1H, left). In contrast, very few submucosal neurons were detected in cKO fetuses (Fig. 1H, right; control, 394.4 ± 10.8 cells/mm2, n = 3; and Gfrα1 cKO, 132.5 ± 15.1 cells/mm2, n = 3; p < 0.001, unpaired t test with Welch's correction). The impairment of SMG formation was not rescued by elevated expression of Bcl-xL (Fig. 2A,B), which allows Ret-deficient enteric neurons to survive in vivo (Uesaka and Enomoto, 2010), suggesting that the lack of submucosal neurons in cKO fetuses was not due to cell death.
Elevated expression of Bcl-xL fails to rescue impaired formation of the submucosal plexus induced by conditional Ret inactivation. A, Schematic diagram showing the strategy of Ret conditional knockout with elevated expression of Bcl-xL in ENS cells. To explore the possibility that impaired formation of submucosal neurons can be explained by cell survival defects, we used Ret-Bcl-xL knock-in mice, in which Ret-deficient enteric neurons can survive. The Ret-Bcl-xL allele contains the wild-type human Bcl-xL cDNA (brown boxes) under the endogenous Ret promoter. Retfl(CFP) mice were mated to RetBcl-xL/+/CAG::CreER mice to obtain control (Retfl(CFP)/+/CAG::CreER) and cKO/Bcl-xL (Retfl(CFP)/Bcl-xL/CAG::CreER) fetuses in the same litter. B, Whole-mount GFP (green) and PGP9.5 (magenta) staining of the SMGs in the small intestine from E18.5 control, cKO, and cKO/Bcl-xL fetuses. These fetuses were subjected to 4-OHT treatment at E15.5 to inactivate Ret. Scale bar, 50 μm.
To confirm whether ENS precursors in the MGs invade the submucosal region in a GDNF-dependent manner, we labeled SMG precursors and neurons transiently and genetically by crossing Gfrα1fl(GFP)/+/Retfl(CFP)/+ mice with RetCreERT2/+ mice (Luo et al., 2009) (Fig. 3A). The RetCreERT2/+ system provides more precise information about the cell fate of labeled ENS precursors, as this had undetectable background recombination activity without 4-OHT (data not shown). After Cre-mediated activation of GFP expression at E13.5, GFP-labeled cells were analyzed at E14.5 and E18.5 (Fig. 3B). At E14.5 in control (Gfrα1fl(GFP)/+/RetCreERT2/+) embryos, 20.1 ± 5.5% (n = 3) of GFP-labeled ENS cells in the MGs did not yet express a neuronal marker, PGP9.5 (Fig. 3C, top). At E18.5, most GFP+ cells were detected as PGP9.5+ neurons in both the MGs and the SMGs (Fig. 3D, top), indicating that GFP-labeled ENS precursors migrate from the MGs to the submucosal layer and differentiate into neurons. Similarly, we examined the cell fates of ENS precursors lacking RET activity. In Ret cKO (Retfl(CFP)/CreERT2) mice, 24.5 ± 2.9% (n = 3) of GFP+ cells in the MGs were PGP9.5− cells at E14.5 (Fig. 3C, bottom), and then at E18.5 GFP-labeled cKO cells failed to invade into the submucosal region and were retained in the MGs (Fig. 3D, bottom panels). These data suggest that RET signaling is essential for radial migration of ENS precursors from the MGs to the submucosal layer.
ENS precursors in the MGs invade the submucosal region in a RET-dependent manner. A, Schematic diagram showing the genetic fate-mapping method to trace the lineage of submucosal neurons from RetCreERT2/+/Gfrα1fl(GFP)/+ (control) or Retfl(CFP)/CreERT2 (Ret cKO) ENS precursors in the MGs. A gene cassette comprising floxed (black triangles, loxP sites) mouse Gfrα1 cDNA (brown boxes) with intron polyA, and GFP reporter (green boxes) was introduced into exon 2 (black boxes) of the mouse Gfrα1 locus (black lines). A gene cassette comprising floxed human Ret9 cDNA (magenta boxes) with intron polyA, and CFP reporter (blue boxes) or CreERT2 cDNA (orange boxes) was introduced into exon 1 of the mouse Ret locus. B, Cre activation was induced by the administration of 4-OHT at E13.5, and GFP+ ENS cells were analyzed at E14.5 and E18.5. C, Immunofluorescence staining for PGP9.5 (magenta) and GFP (green) on control and cKO MGs at E14.5. High- and low-GFP-expressing cells were observed in the myenteric plexus in both control and cKO midgut. D, Immunofluorescence staining for PGP9.5 (magenta) and GFP (green) on control and cKO MGs and SMGs at E18.5. The SMGs in control small intestine contained GFP+ neurons (arrowheads), whereas Ret cKO mice display no GFP+ cells in the submucosal region. Scale bar, 50 μm.
GDNF is likely to be a primary ligand for the GFRα1/RET receptor complex on ENS precursors, as it binds with the highest affinity to the GFRα1 and Gdnf+/− mice have fewer submucosal neurons (Gianino et al., 2003). However, there is also weak cross talk in vitro between GFRα1 and other GDNF family ligands (GFLs), neurturin (NRTN), and artemin (ARTN; Airaksinen and Saarma, 2002), and Nrtn−/− mice have 35% fewer submucosal neurons in the small intestine (Gianino et al., 2003). To examine the possibility that NRTN or ARTN contributes to radial migration of ENS precursors, we analyzed Nrtn- and Artn-deficient mice (Heuckeroth et al., 1999; Honma et al., 2002). Mice deficient for these GFLs showed early SMG formation with no apparent developmental abnormalities (Fig. 4A,B), indicating that neither NRTN nor ARTN are implicated in radial migration of ENS precursors. Altogether, these data indicate that a GDNF–GFRα1/RET signaling cascade is essential for triggering both the primary and secondary migration of ENS precursors to form the MGs and the SMGs, respectively.
NRTN and ARTN signals are dispensable for radial migration of ENS precursors. A, PGP9.5 (green) staining of the SMGs in P0 WT, Nrtn−/−, and Artn−/− mice. B, Quantification of submucosal neurons in the middle portion of the small intestine of WT, Nrtn−/−, and Artn−/− mice at P0. Because GFRα1/RET receptor complex mainly mediates GDNF signaling, and because Nrtn- or Artn-deficient mice display no apparent deficits in the formation of submucosal neurons, the ligand that associates with the GFRα1/RET signaling cascade for the formation of the SMGs is likely to be GDNF. Scale bars, 20 μm.
GDNF expression shifts to the submucosal side of circular muscle layers
Although GDNF expression in the gut mesenchyme persists throughout development, changes in the levels of GDNF expression have been reported during gut colonization by ENS precursors (Golden et al., 1999; Natarajan et al., 2002). Since secondary migration of ENS precursors to the submucosal layer is also triggered in response to GDNF, we examined Gdnf expression pattern during formation of the SMGs in the small intestine by detecting βgal in GdnflacZ/+ mouse gut (Moore et al., 1996) and with specific anti-GDNF antibody. During the rostral-to-caudal migration of ENS precursors along the gut, high βgal immunoreactivity was observed in the outer gut mesenchyme (Fig. 5A). After formation of the MGs, the expression of βgal in the muscle layers was reduced in the small intestine. At this stage, βgal immunoreactivity was detected in the submucosal side of circular muscle layers (Fig. 5B, top). GDNF immunostaining confirmed that GDNF is relatively abundant in the circular muscle layers (Fig. 5C, top). These specific immunoreactivity patterns were readily distinguished from the nonspecific staining observed in negative controls. In wild-type (WT) mice, βgal immunoreactivity was not observed in circular muscle layers (Fig. 5B, bottom), and Gdnf deficiency abolished GDNF immunoreactivity in the gut (Fig. 5C, bottom). Changes in GDNF expression pattern probably lead to changes in GDNF availability that influences the cellular response of ENS precursors. GDNF could be crucial to the entire ENS development during early to late gestational stages.
GDNF expression shifts to the submucosal side of the circular muscle layers. A, GDNF expression in the midgut at E13.5. Intestinal sections from GdnflazZ/+ embryos were stained with βgal (green), PGP9.5 (blue), and smooth muscle actin (SMA; magenta) antibodies. During the rostro-to-caudal migration of ENS precursors along the midgut, high βgal immunoreactivity was observed in the outer gut mesenchyme. B, GDNF expression shift to the submucosal region after formation of the MGs in the small intestine at E18.5. βgal immunoreactivity (arrowheads) was detected in the submucosal side of circular muscle layers in the small intestine from GdnflazZ/+ mice. In negative control (WT mice), βgal immunoreactivity was not observed in circular muscle layers. C, GDNF immunostaining at E18.5 (green) confirmed that GDNF is relatively abundant in the circular muscle layers. In negative controls (Gdnf KO mice), GDNF immunoreactivity was not observed in circular muscle layers. LM, Longitudinal muscle layer; CM, circular muscle layer. Scale bars, 50 μm.
ENS precursors in the myenteric plexus show low activation of RET signaling pathway
ENS precursors are retained in the MG until ∼E15.5, and then begin radial migration toward the submucosal region in response to GDNF. During MG formation, RET is expressed in both ENS precursors and differentiating neurons. To examine the differences in GDNF availability in retained ENS precursors and differentiating neurons during MG formation, we examined the activation levels of ERK, which is a crucial downstream effector of RET. We used RetGFP/+ gut to visualize ENS precursors and differentiating neurons, and distinguished ENS precursors from differentiating neurons by coexpression of GFP and Sox10. At E12.5, GFP+-Sox10+ ENS precursors showed low or undetectable levels of ERK phosphorylation (Fig. 6A,B). Similarly, in mitotic ENS precursors, the level of pERK did not change significantly (Fig. 6B). Upregulation of the pERK was mainly seen in GFP+-Sox10− differentiating neurons (Fig. 6A,B). To confirm that upregulated pERK activity in differentiating neurons is a downstream effect in the GDNF–GFRα1/RET pathway, we examined whether pERK expression diminished when the Gfrα1 gene was deleted in enteric neurons. At E13.5 in Gfrα1 cKO midgut 1 d after treatment with 4-OHT, pERK was detected in GFP−-TuJ1+ neurons (Gfrα1-expressing neurons; Fig. 6C, arrows), whereas the level of pERK was significantly reduced in GFP+-TuJ1+ neurons (Gfrα1-deficient neurons; Fig. 6C,D). These results validated ERK activation in neurons as occurring downstream of GDNF–GFRα1/RET signaling. Our findings suggest that minimal activation of the ERK by GDNF may be crucial for the maintenance of the immature state in ENS precursors.
ENS precursors in the MGs show low activation of RET signaling pathway. A, Immunohistochemical staining for GFP, Sox10, and MAPK (pERK) pathways in E12.5 RetGFP/+ midgut. Phosphorylation of ERK was mainly observed in GFP+-Sox10−-differentiating neurons (arrowheads) but not in GFP+-Sox10+ ENS precursors. B, Quantification of pERK immunofluorescence from GFP+-Sox10− neuronal lineage cells (n = 20), GFP+-Sox10+ undifferentiated cells (n = 20) or mitotic GFP+-Sox10+ cells (open arrowheads, n = 11). Values are normalized to GFP+-Sox10−. *p < 0.05, unpaired t test with Welch's correction. Error bars represent SEM. C, Downregulation of pERK in Gfrα1-deficient enteric neurons. Activation of ERK (pERK) was detected in GFP−-TuJ1+ control neurons (GFP−-TuJ1+, arrows). By contrast, the level of pERK was reduced in Gfrα1-deficient neurons (GFP+-TuJ1+, arrowheads). D, Quantification of pERK immunofluorescence from control neurons (n = 10) or Gfrα1-deficient neurons (n = 10). Values are normalized to GFP−-TuJ1+. *p < 0.05, unpaired t test with Welch's correction. Error bars represent SEM. Scale bars: A, 20 μm; C, 5 μm.
Lack of GDNF signaling leads to inhibition of neuronal differentiation and persistence of ENS precursors
During formation of the MGs, ENS precursors exhibit a low level of RET/ERK pathway activation. We examined whether the loss of GDNF signaling results in the persistence of ENS precursors in addition to an interruption of their migration. We used Retfl(CFP)/+/CAG::CreER mice as a control and Retfl(CFP)/CreERT2 mice as Ret cKO. These animals were treated with 4-OHT at E10.5 and analyzed at E15.5 (Fig. 7A). In the MGs of control midgut (n = 4) at E15.5, 32.6 ± 3.0% of total GFP+ ENS cells coexpressed Sox10, and we also found that ENS cells with relatively strong GFP expression exhibited neurite outgrowth (Fig. 7B, left panels). In contrast, inactivation of Ret in ENS precursors at E10.5 resulted in an approximately twofold increase in the population of GFP+ cells coexpressing Sox10 in the MGs of the midgut at E15.5 (Ret cKO, 69.8 ± 3.5%, n = 3; control, 32.6 ± 3.0%, n = 4; Fig. 7B, right panels, D). These GFP+-Sox10+ double-labeled cells coexpressed the ENS precursor marker Phox2b (data not shown). We further confirmed that the inactivation of Ret in ENS precursors at E10.5 resulted in a significant decrease in the neuronal population of total GFP+ cells at E15.5 (Fig. 7C,D; control, 71.3 ± 6.6%, n = 4; vs cKO, 8.6 ± 0.9%, n = 3; p < 0.05, unpaired t test with Welch's correction).
The lack of GDNF availability leads to the inhibition of neuronal differentiation and persistence of ENS precursors. A, Embryonic midgut was dissected out from E15.5 control and Ret cKO fetuses in which Ret inactivation was induced at E10.5. B, Colabeling with GFP (Ret) and Sox10 to distinguish undifferentiated cells (GFP+-Sox10+ cells) from glial lineage cells (Sox10+ cells) and neuronal lineage cells (GFP+ cells). In Ret cKO MGs, GFP+-Sox10+ double-positive cells were easily found (arrowheads). C, Neuronal differentiation of control and Ret cKO ENS precursors in the midgut. In controls at E15.5, many GFP+ cells were labeled by PGP9.5 (open arrowheads), but not in cKO MGs. D, Quantification of the fraction of GFP+-Sox10+ double-positive cells and GFP+-PGP9.5+ double-positive neurons within the GFP+ cells in the MGs of E15.5 control (n = 4) and Ret cKO mice (n = 3). *p < 0.05, unpaired t test with Welch's correction. Error bars represent SEM. E, Dividing cells in Ret cKO GFP+ cells colabeled by Sox10 at E15.5. Scale bars, 50 μm.
Previous in vitro studies have shown that GDNF promotes neuronal differentiation but not glial differentiation (Chalazonitis et al., 1998). Consistent with this, conditional inactivation of Gfrα1 at E10.5 led to a significant reduction in the GFP+-PGP9.5+ neuron population of total GFP+ cells in the midgut at E15.5 (control, 34.1 ± 5.0%, n = 7; vs cKO, 19.8 ± 2.0%, n = 7; p < 0.05, unpaired t test with Welch's correction), but had no impact on glial cell population detected by coexpression of GFP and brain lipid-binding protein (control, 48.7 ± 2.6%, n = 3; vs cKO, 46.7% ± 2.4%, n = 3). Thus, these data suggest that GDNF signaling is required for neuronal differentiation in vivo. We showed previously that the inactivation of GDNF signaling at E13.5 does not lead to widespread neuronal death in the midgut (Uesaka et al., 2007), although the possibility that a minimal number of neurons may die cannot be excluded. Gfrα1 inactivation also reduced cell proliferation, but Gfrα1-deficient ENS precursors still exhibited low proliferative capacity (Uesaka et al., 2007). We found mitotic figures and dividing cells in GFP+-Sox10+ cKO cells at E15.5 (Fig. 7E). Together, our findings suggest that insufficient access to GDNF may lead to the persistence of ENS precursors in the MGs until the developmental stage of the SMGs.
ENS precursors lacking GDNF availability retain migratory and neurogenic potential
If insufficient access to GDNF does lead to an interruption of ENS precursor migration and neuronal differentiation, then the restoration of GDNF signaling should restart their migration and neuronal differentiation. As soluble GFRα1-Fc has been previously shown to activate RET in response to GDNF even in cells lacking endogenous GFRα1 (Yu et al., 1998; Paratcha et al., 2001), we attempted to restore GDNF signaling in Gfrα1-deficient ENS precursors in gut organ culture. Control (Gfrα1fl(GFP)/+/CAG::CreER) and cKO (Gfrα1fl(GFP)/−/CAG::CreER) embryos were treated with 4-OHT at E10.5, and the entire gut dissected 16 h later was maintained in organ culture (Fig. 8A). In control embryos, ENS precursors colonized the entire midgut, whereas Gfrα1-deficient ENS precursor failed to reach the cecum (Fig. 8B). The entire gut of Gfrα1 cKO embryos was placed in organ culture medium with vehicle (BSA) or soluble GFRα1-Fc and incubated for 16 h. Although the impaired migration of ENS precursors was not improved in the gut cultured with vehicle (BSA), soluble GFRα1-Fc could partly restore a rostral-to-caudal migration and neuronal differentiation (Fig. 8C), suggesting that ENS precursors that failed to migrate due to insufficient access to GDNF can maintain migration potential in response to GDNF signaling. We further examined whether GDNF signal recovery could restore neuronal differentiation of ENS precursors 4 d after inactivation of Gfrα1 in gut explant culture (Fig. 8D). In cKO explants, GFP+ ENS cells lacking Gfrα1 aggregated into clumps, and TuJ1+ neurons were sparse. These findings suggest that migration and neuronal differentiation of ENS precursors were repressed by the lack of GDNF signaling. Subsequently, BSA and GDNF were administered, but these treatments had no impact on neuronal differentiation of Gfrα1-deficient ENS cells (Fig. 8E, top panels). In contrast, soluble GFRα1-Fc and GDNF treatment restored migration of GFP+ cells from the high-density region and induced neuronal differentiation of GFP+ precursors surrounding the high-density region (Fig. 8E, bottom panels). We found a significant increase in GFP+ neuron numbers in Gfrα1 cKO gut after treatment with GDNF and GFRα1-Fc (Fig. 8F), suggesting that Gfrα1-deficient ENS precursors retain the potential to differentiate into neurons. Altogether, these findings support the idea that insufficient activation of GDNF signaling leads to the pausing state of ENS precursors during MG development.
ENS precursors lacking GDNF availability retain migratory and neurogenic potential. A, 4-OHT was administered to pregnant females at E10.5. Embryonic guts were dissected out from Gfrα1 cKO fetuses 16 h after injection of 4-OHT and cultured in medium with vehicle (BSA) or soluble GFRα1-Fc for another 16 h. The incubation period of the gut explant is shown as a thick line. B, GFP+ cells (green) in the gut of control and Gfrα1 cKO fetuses 16 h after injection of 4-OHT at E10.5. In the control fetuses, GFP+ cells entered the hindgut, whereas inactivation of Gfrα1 impaired ENS precursor migration. C, Whole-mount GFP (green) and TuJ1 (magenta) staining of cKO gut cultured for 16 h in the presence of vehicle (BSA) or soluble GFRα1-Fc. In the gut treated with soluble GFRα1-Fc, GFP+ cells entered into the hindgut, and TuJ1+ neurons were observed in the cecum. D, Embryonic guts were dissected out from E11.5 Gfrα1 cKO fetuses 1 d after injection of 4-OHT, cultured in medium for 3 d, and then treated with GDNF and vehicle (BSA) or soluble GFRα1-Fc for 1 d. The incubation period of gut explant is shown as a thick line. E, Recovery of GDNF signaling by soluble GFRα1-Fc-induced neuronal differentiation of ENS precursors. In gut explants from Gfrα1 cKO embryos, GFP+ cells (green) were observed with high cell densities, and neurons (magenta) were sparse during the long-term incubation. GDNF and BSA had no impact on neuronal differentiation. In contrast, GDNF and soluble GFRα1-Fc administration induced migration of some GFP+ cells from the region of high density of GFP+ cells and neuronal differentiation. F, Quantification of the percentage of TuJ1+ neurons coexpressing GFP in Gfrα1 cKO gut cultured in medium for 3 d, and then treated with GDNF and vehicle (BSA; n = 3) or soluble GFRα1-Fc (n = 3) for 1 d. *p < 0.05, unpaired t test with Welch's correction. Error bars represent SEM. Mg, Midgut; Hg, hindgut. Scale bars, 50 μm.
Discussion
Our study provides evidence that GDNF signaling regulates the development of the SMGs at least in part by promoting radial migration of ENS precursors. During midgestation (E13.5–E15.5), premigratory SMG precursors are located in the myenteric layer and are surrounded by neuronally differentiating cells destined to form the MGs. Because SMG development occurs substantially later than MG development (Gershon et al., 1993), SMG precursors must remain in an immature state for a longer period than do MG precursors. Our immunohistochemical analysis revealed that premigratory SMG precursors exhibit low levels of ERK phosphorylation, suggesting that suppressing the full activation of ERK is required for the maintenance of the immature state in ENS precursors. The availability of GDNF is limited in vivo (Shen et al., 2002; Gianino et al., 2003), which can be disadvantageous, as any defects that affect GDNF signaling may confer susceptibility to Hirschsprung disease. We speculate, however, that limited GDNF availability is important for normal ENS development, as it seems to play a role in maintaining ENS precursors in the immature state for the long term. Thus, the development of the ENS is regulated by exquisite control of GDNF signaling.
GDNF is essential to drive rostrocaudal and radial migration of ENS precursors
Previously reported in vitro studies have shown that GDNF is chemoattractive to ENS precursors (Young et al., 2001; Natarajan et al., 2002), suggesting that GDNF is required for the directional migration of ENS precursors toward the caudal end of the small intestine and for retaining ENS precursors within the gut wall. Our finding is that GDNF is required to drive ENS precursor migration in vivo, and thus ENS precursors lacking GDNF are retained within the gut wall. ENS precursor migration activities depend on the activation level of RET, as reduction in Ret expression to ∼30% of normal level, which does not affect proliferation (Nishiyama et al., 2012), and survival of ENS precursors (Uesaka and Enomoto, 2010) result in the delay of gut colonization by ENS precursors, implying that ENS precursors with sufficient access to GDNF can continue to migrate selectively at the migratory wave front.
We further demonstrate that GDNF is also essential for triggering secondary inward migration of ENS precursors toward the submucosal region. Netrin-mediated guidance has previously been implicated in the radial migration of ENS precursors (Jiang et al., 2003). While GDNF signaling is essential for triggering radial migration of ENS precursors (Figs. 2, 3), netrins likely cooperate to promote radial migration as guidance cues.
Gfrα1 cKO ENS precursors exhibit a polarized morphology, that is, extension of the leading process, whereas the motility of the cell body is slowed. Similar impairment of neuronal migration has been observed in precursors of GABAergic interneurons deficient in Rho-regulated active nucleators mammalian diaphanous homolog 1 (mDia1) and mDia3 (Shinohara et al., 2012). The Rho signaling via mDia and Rho-associated protein kinase (ROCK) is one of the candidate signaling pathways that have been suggested to regulate ENS precursor migration in response to GDNF. For instance, the phosphorylation of the serine residue at codon 696 (S696) of human RET is required for GDNF-mediated activation of RAC1-guanine nucleotide exchange factor in vitro (Fukuda et al., 2002), and RET S697A mutant mice (corresponding to S696 in human RET) show a migration defect of ENS precursors (Asai et al., 2006). Moreover, the inhibition of ROCK suppresses ENS precursor migration in gut explants, and these effects may be RET dependent (Stewart et al., 2007). Further experiments will be needed to determine whether Rho signaling acts downstream of RET in ENS precursor migration.
GDNF is required for triggering neuronal differentiation of ENS precursors
In postmigratory ENS precursors, GDNF signaling promotes neuronal precursor proliferation (Gianino et al., 2003; Wang et al., 2010) and is required for neuronal differentiation. Previous studies in primary cultures show induction of neuronal differentiation by administration of GDNF (Chalazonitis et al., 1998; Hearn et al., 1998; Taraviras et al., 1999; Ngan et al., 2008). In gut explants, GDNF promotes ENS precursor proliferation in the early phase of culture, whereas it promotes neuronal differentiation in later culture periods (Fu et al., 2004), suggesting that GDNF promotes neuronal differentiation at a later postmigratory stage. However, results of in vivo studies are controversial. In the chick embryo, both overexpression and inhibition of Gdnf induces premature neuronal differentiation (Mwizerwa et al., 2011). In mice heterozygous for Gdnf, which have a reduced rate of neuronal precursor proliferation (Gianino et al., 2003), the rate of neuronal differentiation tends to be higher than that in WT mice (Flynn et al., 2007). Our findings clearly demonstrate that ENS precursors lacking GDNF availability do not differentiate into neurons.
Furthermore, we show that inactivation of GDNF leads to the maintenance of ENS precursors in an undifferentiated state, and that GDNF signal recovery can restart neuronal differentiation of ENS precursors lacking GDNF signaling in gut organ culture. Thus, GDNF is required for triggering neuronal differentiation of ENS precursors, and insufficient activation of GDNF signaling appears to be important for the persistence of noncommitted precursors within the MGs until they receive sufficient GDNF signaling for the formation of the SMGs.
Bone morphogenetic proteins (BMPs) also play a role in the long-term developmental processes of the ENS. In vitro neuronal differentiation is enhanced by low concentrations and is reduced by high concentrations of BMP2 or BMP4 (Chalazonitis et al., 2004). In vivo, overexpression of the BMP inhibitor noggin leads to an increase in the number of enteric neurons in both MGs and SMGs, and a decrease in the generation of late-born neurons (Chalazonitis et al., 2008). Combinations of high activation levels of BMP signaling and insufficient activation of GDNF may restrict the extent of neuronal differentiation that occurs during early ENS development.
In Ret-null mice, early migrating ENS precursors undergo massive apoptosis in the foregut at E10.5 (Taraviras et al., 1999; Uesaka et al., 2008). In contrast, at least a portion of ENS precursors in which Ret is inactivated during their migration in the midgut at E10.5 can survive and remain in an immature state. In addition to resistance to the cell death of ENS precursors in the small intestine, postmitotic enteric neurons in the small intestine are also resistant to neuronal death by inactivation of GDNF signaling, in contrast to massive neuronal death in the distal colon (Uesaka et al., 2007, 2008). Since ENS precursors in culture die rapidly without GDNF (Taraviras et al., 1999), other factors, including neurotrophin-3 and serotonergic signaling via the 5-HT4 receptor (Chalazonitis et al., 2001; Liu et al., 2009), if any, may support ENS precursor and neuron survival in the small intestine during ENS development. In addition, the close spatial proximity of regions releasing various survival factors appears to augment trophic support promoting ENS cell survival. This situation is different from many other regions of the peripheral nervous system in which a supply of a neurotrophic factor is restricted to the nerve target region. ENS precursors may receive overlapping graded survival signals, which make GDNF signaling a unique requirement for survival in a spatiotemporally restricted pattern.
During development of the MGs, ENS precursors show a lower activation level of ERK by GDNF compared with differentiating neurons. One study reported that activation of the MAPK is necessary for ENS precursor migration. However, their chemotactic response to GDNF is maintained even under conditions of efficient inhibition of the MAPK pathway (Natarajan et al., 2002). Consistent with this, MEK1 inhibitor exhibits little effect on ENS precursor migration in the hindgut (Asai et al., 2006). Another group failed to observe any correlation between ERK activity and migration velocity by ex vivo imaging with FRET biosensors (Goto et al., 2013). Thus, ERK/MAPK cascade may play an important role in neuronal differentiation, and immature ENS precursors may migrate and stay with low levels of ERK activation.
Although our study provides evidence that GDNF signaling levels are highly correlated to the differentiation status of ENS precursors, the exact molecular mechanisms regulating the GDNF signaling levels remain elusive. We speculate that both intracellular and extracellular machineries are involved. As for the former, the maintenance of low levels of ERK activation could be due to at least two possibilities: (1) ENS precursors fail to get sufficient access to GDNF; or (2) the GDNF signaling pathway is inhibited by negative regulators that include Sprouty (Spry). Sprouty inhibits GDNF-induced ERK activation in vitro (Ishida et al., 2007), and an in vivo study with Spry2-deficient mice reported that ERK and AKT are hyperactive in response to GDNF in enteric neurons (Taketomi et al., 2005). We therefore examined whether Spry2 deletion leads to activation of ERK in ENS precursors, and, consequently, the depletion of SMG precursors by facilitating differentiation into myenteric neurons. In Spry2-null mice, we found ENS precursors with a lower activation level of ERK compared with differentiating neurons, and SMG formation was not impaired (data not shown). These data suggest that a low activation level of ERK is not due to Spry2-mediated inhibition.
The extracellular environment also appears to influence GDNF signaling levels. Differences in the availability of GDNF can occur among ENS precursors, because several previous studies have suggested that GDNF protein seems to be retained close to its site of synthesis. For instance, GDNF overexpression in Myo-Gdnf or GFAP-Gdnf transgenic mice has no impact on the serum levels of GDNF (Zhao et al., 2004), and axonal sprouting was elicited locally at the site of GDNF administration in the brain (Rosenblad et al., 1999; Kirik et al., 2000). Spatially restricted action of GDNF upon ENS precursors may be explained by the binding of GDNF to 2-O-sulfate-rich, heparin-related glycosaminoglycan (Rickard et al., 2003), and to GFRα1 expressed by mesenchymal and glial lineage cells in an autocrine fashion. Further studies will be required to fully understand the regulatory mechanism of GDNF signaling in ENS precursors.
In summary, our data indicate that GDNF can drive the migration of ENS precursors expressing Sox10, which is required for maintenance of the undifferentiated precursor state, and inhibits neuronal differentiation of NC stem cells (Kim et al., 2003). In addition, GDNF signaling contributes to the downregulation of Sox10 in ENS precursors and triggers neuronal differentiation, whereas ENS precursors that persist in the MG exhibit minimal activation of GDNF signaling. By exquisite control of GDNF signaling in ENS precursors, the ENS is able to balance MG formation and SMG precursor cell maintenance, ensuring proper development of the SMGs. These findings are highly relevant to human diseases that affect ENS precursors, such as Hirschsprung disease. They also provide novel insights into the molecular mechanisms that regulate ENS precursor cell maintenance and differentiation, and will enhance future attempts to replace missing neurons in the gut.
Footnotes
This work was supported by RIKEN and Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas, “Cellular and Molecular Basis for Neuro-Vascular Wiring”). We thank the Laboratory for Animal Resources and Genetic Engineering for their excellent technical assistance. We also are grateful to D. Sipp and H.S. Hiraga for editing this manuscript.
The authors declare no competing financial interests.
- Correspondence should be addressed to Hideki Enomoto, Division of Neural Differentiation and Regeneration, Department of Physiology and Cell Biology, Graduate School of Medicine, Kobe University, 7-5-1, Kusunokicho, Chuo-ku, Kobe 650-0017, Hyogo, Japan. enomotoh{at}med.kobe-u.ac.jp
